Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.


2024-12-22	0 0 %
2023-12-31	0 0 %
2022-12-31	0 0 %
2021-12-31	0 0 %
2020-12-31	0 0 %
2019-12-31	0 0 %
2018-12-31	0 0 %
2017-12-31	0 0 %

Helius Medical Technologies, Inc.

HSDT | NASDAQ Capital Market

On 2024-12-22, the Dividend Yield for Helius Medical Technologies, Inc. was recorded at 0%, with a 0% adjustment.